ANRO Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Pipeline DIN Q1 2026 Earnings EPS Surpasses Estimates by 529 DAVE Q1 2026 Earnings EPS Beats Estimates by 37 Stock Declines on Lack of Revenue Details Stereotaxis STXS Q1 2026 Earnings EPS Miss Reflects Ongoing Investment in Robotic Cardiology Platform IOVA Q1 2026 Earnings EPS Miss Becomes a Buying Opportunity as Shares Jump UZD Q1 2026 Earnings Significant EPS Beat Drives Stock Uptick